Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Formulation
Global Vaccine Market Rises to the TopAgain2022-11-17
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA2022-11-17
he worlds first! RSV prevention therapy for infants young children was approved, the tens of billions of market ushered in a competitive battle2022-11-17
Fastest Times="32" billion ADC drug? Who can fight Enhertu for Breast cancer?2022-11-09
Pfizers paxlovid reduces the risk of COVID-19 by 26%2022-11-09
The battle between Pfizer Gilead over COVID-19 drugs will continue2022-11-04
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease2022-11-02
With a $10 billion market a clinical shortage, the first "Snoring medicine" is expected to hit the market2022-11-02
FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Discovery?2022-11-02
More than 40 products into the clinical! Claudin18.2 Target, who will dominate?2022-11-02
The worlds first Upadatinib extended-release tablets approved by FDA for non-radiological axial spondyloarthritis2022-11-02
JAK inhibitor, the successor to Hummero?2022-11-02
India starts testing a pharmaceuticalcompanys exports of cough syrup2022-10-24
New regulations on online sales of drugs clarify the management of online sales of prescription drugs2022-10-20
Flu new drug approved only 1 year, Shi Yao Ou Yi that is the first copy! Roche responds...2022-10-20
A quarter of a billion dollars! Merck Partners with Moderna to Advance mRNA cancer Vaccine plus K drug for melanoma2022-10-20
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy2022-10-20
When is "water inverse" going on? Biogens ALS drug approval delayed to next April2022-10-20
Not as good as a placebo? Relmada Therapeutics Shares plunge 80% after Phase 3 trial of New Drug for Major Depression fails!2022-10-20
With a second drug in Phase III for Alzheimers, Can Bonjian turn the tide this time?2022-10-18
From the long-term insulin Icodec phase III study GrSlam, looking at the development history of Novo Nordisk2022-10-18
With a second drug in Phase III for Alzheimers, Can Bonjian turn the tide this time?2022-10-18
Semaglutide: Another phenomenon-level new drug, breaking one billion in "seconds", the "weight loss" market is basically out of stock2022-10-14
Preliminary clinical success of Pfizers oral GLP-1 agonist2022-09-30
New study shows that daily multivitamins may ameliorate Alzheimers disease2022-09-30
Market Report of Monoclonal Antibody Drugs in China (2022)2022-09-20
Chinas National Health Insurance Bureau is studying the inclusion of innovative medical supplies into medical insurance2022-08-31
FDA approves ibrutinib for chronic graft-versus-host disease in children 1 year older2022-08-31
First BCMA/CD3 dual antibodies approved by EU2022-08-31
FDA Approves Bluebird Gene Therapy Zynteglo2022-08-23
CXO -- Booming industry strong demfor R&D2022-08-23
Pharmaceutical Equipment - Continued prosperous development, biologics market expansion brings important drivers2022-08-23
1422个 页次:1/4532个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463